Metraipolis › archive › dc_9f02533ea6d3

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition,… — Europe PMC PMID:42414479

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42414479
DOI
10.1038/s41416-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-10-18T10:42:50.296Z
SHA-256 of the archived text
a159f1edad49b022543758b1e593168541da81288f2944a228e1f7ebc6d948ce
Stable URL of this page
https://metraipolis.com/documento/dc_9f02533ea6d3

How to cite

Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition,… — Europe PMC PMID:42414479 — Europe PMC (en), https://europepmc.org/article/MED/42414479 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9f02533ea6d3 (Metraipolis archive dc_9f02533ea6d3, sha256 a159f1edad49b022543758b1e593168541da81288f2944a228e1f7ebc6d948ce)
BibTeX
@misc{dc9f02533ea6d3,
  title = {Functional and omics-based rationale for the induction of BRCAness by androgen receptor pathway inhibitors to sensitize prostate cancer to PARP inhibition,… — Europe PMC PMID:42414479},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42414479},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9f02533ea6d3; sha256 a159f1edad49b022543758b1e593168541da81288f2944a228e1f7ebc6d948ce},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42414479. Agents can read the archived copy with the MCP tool read_document.